Vision and mission

Our vision is to be a leading company in providing antiviral therapeutics.

Our mission is to leverage our proprietary knowledge and extensive networks to develop an effective, novel broad-spectrum antiviral therapy.

Delivering on our vision and mission rests on the high quality of our people, partners and proprietary product:

• People – our team brings extensive knowledge and experience in successfully navigating the translation and commercialisation of products that improve human health. 
  
  
• Partnerships – our strong relationships with leading researchers and consultants ensure we can access the best science, research and innovation.
  
  
• Proprietary product – developing and commercialising our novel Antiviral Triple Therapy (ATT) designated TPL101 could help protect and improve the health and well-being of millions of people whilst generating a strong, scalable business model.